NAS
AGIO icon

Nykredit A/S’s Agios Pharmaceuticals AGIO Stock Holding History

Nykredit A/S’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.1K Buy
+703
New +$21.3K ﹤0.01% 1658

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Nykredit A/S's AGIO Position: Q2 2026 in Review

Nykredit A/S opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 703 shares worth $26.1K. The stake represents ﹤0.01% of the portfolio and ranks #1658 among its holdings.

157 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Nykredit A/S held 703 shares of Agios Pharmaceuticals worth $26.1K as of Q2 2026.
  • Agios Pharmaceuticals was a new Nykredit A/S position in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1658 holding.
  • 157 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.